Botanix Pharmaceuticals Limited

About BOT.AX

Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs.

Related

News

Cramer weighs in on Goldman amid CEO succession talks — plus, Boeing bounces back

CNBC · 2h ago

Gina Raimondo thinks AI ultimately will create jobs. It's the initial mass layoffs wave that worries her

CNBC · 2h ago

N/A

Iranians stagger under soaring costs of seven months of war - Reuters

Reuters · 3h ago

N/A

Iraqi Airways to resume Iran flights in October after securing 'special exemption' - Reuters

Reuters · 4h ago

Investors who have shunned diversification face maybe the best buying opportunity for bonds in decades

CNBC · 4h ago